{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:54:31Z","timestamp":1761562471738,"version":"3.37.3"},"reference-count":23,"publisher":"Portland Press Ltd.","issue":"3","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In the last two decades, our understanding of the genetic underpinnings of inherited podocytopathies has advanced immensely. By sequencing the genomes of a large pool of families affected by focal segmental glomerulosclerosis (FSGS), researchers have identified a common theme: familial podocytopathies are frequently caused by genes selectively expressed in podocytes. Podocalyxin is a podocyte-specific surface sialomucin that has long been known to play important roles in podocyte morphogenesis and function. Few studies, however, have shown a conclusive link between mutations in the gene and FSGS complemented by functional evidence. In a fascinating new paper published in Clinical Science, Lin et al. identify two unrelated pedigrees in which dominant loss-of-function mutations in PODXL lead to adult-onset FSGS. Nonsense-mediated decay of the mutated PODXL transcripts leads to protein insufficiency, which in turn cause podocyte dysfunction through defects in motility and cytoskeletal organization. This is the first study to date that demonstrates, mechanistically, how autosomal dominant mutations in podocalyxin can lead to FSGS and renal insufficiency. Here, we summarize the experimental findings of this manuscript and propose, perhaps, a more controversial hypothesis: down-regulation of podocalyxin protein expression from podocytes is a critical turning point in the progression of most podocytopathies and may be mechanistically relevant to glomerulopathies in which podocyte damage is not necessarily induced by genetic lesions.<\/jats:p>","DOI":"10.1042\/cs20181067","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T20:40:12Z","timestamp":1549658412000},"page":"443-447","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The first identified heterozygous nonsense mutations in podocalyxin offer new perspectives on the biology of podocytopathies"],"prefix":"10.1042","volume":"133","author":[{"given":"Ido","family":"Refaeli","sequence":"first","affiliation":[{"name":"The Biomedical Research Centre, University of British Columbia, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael\u00a0R.","family":"Hughes","sequence":"additional","affiliation":[{"name":"The Biomedical Research Centre, University of British Columbia, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4737-3499","authenticated-orcid":false,"given":"Kelly\u00a0M.","family":"McNagny","sequence":"additional","affiliation":[{"name":"The Biomedical Research Centre, University of British Columbia, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"2021113011091394500_B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1042\/CS20180676","article-title":"First identification of PODXL nonsense mutations in autosomal dominant focal segmental glomerulosclerosis","volume":"133","author":"Lin","year":"2018","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011091394500_B2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal Segmental Glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011091394500_B3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2215\/CJN.04121206","article-title":"A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases","volume":"2","author":"Barisoni","year":"2007","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011091394500_B4","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1053\/j.ackd.2014.06.001","article-title":"Familial FSGS","volume":"21","author":"Pollak","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"key":"2021113011091394500_B5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/ki.2013.354","article-title":"Exome sequencing and in vitro studies identified podocalyxin as a candidate gene for focal and segmental glomerulosclerosis","volume":"85","author":"Barua","year":"2014","journal-title":"Kidney Int."},{"key":"2021113011091394500_B6","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1681\/ASN.2008070782","article-title":"The role of podocalyxin in health and disease","volume":"20","author":"Nielsen","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011091394500_B7","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1083\/jcb.98.4.1591","article-title":"Identification and characterization of podocalyxin\u2013the major sialoprotein of the renal glomerular epithelial cell","volume":"98","author":"Kerjaschki","year":"1984","journal-title":"J. Cell Biol."},{"key":"2021113011091394500_B8","first-page":"343","article-title":"Reduced sialylation of podocalyxin\u2013the major sialoprotein of the rat kidney glomerulus\u2013in aminonucleoside nephrosis","volume":"118","author":"Kerjaschki","year":"1985","journal-title":"Am. J. Pathol."},{"key":"2021113011091394500_B9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1681\/ASN.V1281589","article-title":"The glomerular epithelial cell anti-adhesin podocalyxin associates with the actin cytoskeleton through interactions with ezrin","volume":"12","author":"Orlando","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011091394500_B10","doi-asserted-by":"publisher","first-page":"15708","DOI":"10.1074\/jbc.272.25.15708","article-title":"Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin","volume":"272","author":"Kershaw","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2021113011091394500_B11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1084\/jem.194.1.13","article-title":"Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin","volume":"194","author":"Doyonnas","year":"2001","journal-title":"J. Exp. Med."},{"key":"2021113011091394500_B12","doi-asserted-by":"publisher","first-page":"e414","DOI":"10.1038\/emm.2017.227","article-title":"Loss of podocalyxin causes a novel syndromic type of congenital nephrotic syndrome","volume":"49","author":"Kang","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"2021113011091394500_B13","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1002\/stem.2707","article-title":"Gene-edited human kidney organoids reveal mechanisms of disease in podocyte development","volume":"35","author":"Kim","year":"2017","journal-title":"Stem Cells"},{"key":"2021113011091394500_B14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/ki.2013.175","article-title":"Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury","volume":"84","author":"Blattner","year":"2013","journal-title":"Kidney Int."},{"key":"2021113011091394500_B15","doi-asserted-by":"publisher","first-page":"16491","DOI":"10.1074\/jbc.M117.798512","article-title":"Loss of mucin-type O-glycans impairs the integrity of the glomerular filtration barrier in the mouse kidney","volume":"292","author":"Song","year":"2017","journal-title":"J. Biol. Chem."},{"key":"2021113011091394500_B16","doi-asserted-by":"publisher","first-page":"16442","DOI":"10.1073\/pnas.0607872103","article-title":"Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene","volume":"103","author":"Alexander","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011091394500_B17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.humpath.2010.05.028","article-title":"Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome","volume":"42","author":"Kavoura","year":"2011","journal-title":"Hum. Pathol."},{"key":"2021113011091394500_B18","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1177\/0961203317734918","article-title":"The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis","volume":"27","author":"Ikuma","year":"2018","journal-title":"Lupus"},{"key":"2021113011091394500_B19","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1007\/s00125-012-2661-7","article-title":"Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin","volume":"55","author":"Hara","year":"2012","journal-title":"Diabetologia"},{"key":"2021113011091394500_B20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s40620-014-0066-z","article-title":"ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome","volume":"27","author":"Zhu","year":"2014","journal-title":"J. Nephrol."},{"key":"2021113011091394500_B21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3109\/1354750X.2015.1118551","article-title":"Urinary podocalyxin levels were associated with urinary albumin levels among patients with diabetes","volume":"21","author":"Shoji","year":"2016","journal-title":"Biomarkers"},{"key":"2021113011091394500_B22","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2215\/CJN.08110811","article-title":"Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy","volume":"7","author":"Asao","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"2021113011091394500_B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40620-015-0199-8","article-title":"Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity","volume":"29","author":"Suwanpen","year":"2016","journal-title":"J. Nephrol."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/133\/3\/443\/841949\/cs-2018-1067c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/133\/3\/443\/841949\/cs-2018-1067c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:08:19Z","timestamp":1638274099000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/133\/3\/443\/111054\/The-first-identified-heterozygous-nonsense"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,2,14]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20181067","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"type":"print","value":"0143-5221"},{"type":"electronic","value":"1470-8736"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2019,2]]}}}